News

FUND RAISING THROUGH THIRD-PARTY ALLOTMENT OF SHARES

We announces that we have raised a total of 1.8 billion yen through a third-party allotment of new shares by March 22, 2023.

In this round of financing participated the Kyushu Regional Recovery Support Fund, which was established by the Regional Economy Revitalization Corporation of Japan ("REVIC") jointly with local financial institutions in the Kyushu region, in addition to the existing shareholders which are The University of Tokyo Edge Capital Partners Co., Ltd. ("UTEC"), Newton Biocapital and MP Healthcare Venture Management, Inc. which is the corporate venture capital of Mitsubishi Tanabe Pharma Corporation.

For more details, please see FUND RAISING THROUGH THIRD-PARTY ALLOTMENT OF SHARES(PDF)